Sharing successes, challenges and daily happenings in the Department of Medicine
ARTICLE: Long-term risk of tuberculosis among individuals with Xpert Ultra trace screening results in Uganda: a longitudinal follow-up study AUTHORS: Joowhan Sung, Mariam Nantale, Annet Nalutaaya, Patrick Biché, James… Read More »Long-term risk of tuberculosis among individuals with Xpert Ultra trace screening results in Uganda: a longitudinal follow-up study
ARTICLE: Post-COVID-19 cardiovascular disease risk in kidney transplant recipients AUTHORS: Mary G Bowring, Kasama Manothummetha, Veraprapas Kittipibul, Lucy X Li, Robin K Avery, Willa Cochran, Sean Ellis, Ilan S Wittstein, Dorry L Segev, Christine… Read More »Post-COVID-19 cardiovascular disease risk in kidney transplant recipients
Congratulations to the below faculty members who were recently promoted. Associate Professor (pictured) Todd Fojo, GIM Aravindan Kolandaivelu, Cardiology Joanna Miller Peloquin Melia, Gastroenterology Scott Pilla,… Read More »Faculty Promotions & Additions
DOM physicians make up about half of the Johns Hopkins doctors recognized by Baltimore magazine as 2025 'Top Docs.' This accolade highlights peer nominations and votes,… Read More »52 From the DOM Named Top Doctors
Sears Honored with IDSA's Alexander Fleming Lifetime Achievement Award In a ceremony that opened IDWeek 2025, Dr. Cynthia Sears, Professor of Medicine and Oncology, was… Read More »Sears and Melia Receive Awards from the Infectious Diseases Society of America
ARTICLE: Proviruses in CD4+ T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia AUTHORS: Fengting Wu, Milica Moskovljevic, Filippo Dragoni, Sahana Jayaraman, Nathan L… Read More »Proviruses in CD4+ T cells reactive to autologous antigens contribute to nonsuppressible HIV-1 viremia
ARTICLE: Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2… Read More »Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial
The 2025 class of the Miller Coulson Academy of Clinical Excellence will be inducted at the Annual Excellence in Patient Care Symposium on Thursday, October… Read More »McArthur and Nyakinye Receive NP/PA Clinical Excellence Awards
On Thursday, September 18, Professor the Lord Darzi of Denham, OM, KBE, PC, FRS, visited Hopkins to meet with leaders and discuss the Fleming Initiative.… Read More »Professor the Lord Darzi of Denham Visits Hopkins